MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease
- 1 September 2001
- journal article
- Published by Elsevier in The Lancet
- Vol. 358 (9286) , 984-985
- https://doi.org/10.1016/s0140-6736(01)06125-6
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Graves' DiseaseNew England Journal of Medicine, 2000
- Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathyThe Lancet, 1999
- Modification of the Classification of the Eye Changes of Graves' Disease: Recommendations of the Ad Hoc Committee of The American Thyroid AssociationJournal of Clinical Endocrinology & Metabolism, 1977